Concord Biotech Limited
Nifty 500
Smallcap 250
₹1,505.70
+3.64%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.
- Comfortable interest cover: operating profit covers interest about 368 times.
- Return on equity is moderate at 12.5%.
- Return on capital employed is healthy at 17.1%.
- Net profit margin is strong at 24.6%.
- Sales have compounded about 11% a year over five years.
- Pays a dividend (yield about 0.5%).
- Has paid a dividend in each of the last 5 years on record.
- Promoters hold a sizeable stake (44.08%).
!Watch-points
- Profit growth has been slow over five years (about 1% a year).
- Recent profit growth (-22%) is slower than the five-year pace (1%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
6.51
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 15,752 Cr
Current Price₹ 1,505.70
High / Low₹ 1,704.00 / 987.00
Stock P/E51.813488
Book Value₹ 193.00
Dividend Yield0%
ROCE17.10%
ROE12.50%
Face Value₹ 1.00
Debt to Equity0.00
PEG Ratio—
EV / EBITDA35.64
Industry PE35.70
P/B Ratio7.809404
EPS₹ 24.94
Debt₹ 2 Cr
PAT Margin24.55%
Cash PAT₹ 333 Cr
ICR368.00
Promoter Holding44.08%
FII Holding7.53%
DII Holding9.37%
Public Holding39.04%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity